Accordingly, PD-L1 and PD-L2 are found to be overexpressed in a majority of PMBL patients [41,66,71,84] and about 50% of PCNSL and PTL patients harbour PD-1 ligand overexpression [80]. Here, PDCD1LG2 is linked to primary central nervous system lymphoma.